Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linda Howard

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Stem Cell Research|December 29, 2020
Derivation of iPSC lines from three young healthy donors of Caucasian origin (NUIGi035-A; NUIGi036-A; NUIGi037-A)Yicheng Ding, Berta Marcó de la Cruz, Veronica McInerney, et al.
Cytotherapy|August 23, 2022
Marrow changes and reduced proliferative capacity of mesenchymal stromal cells from patients with "no-option" critical limb ischemia; observations on feasibility of the autologous approach from a clinical trialSara Azhari Mohamed, Aoife Duffy, Veronica McInerney, et al.
Stem Cell Research|November 24, 2019
Derivation of familial iPSC lines from three ASD patients carrying NRXN1α<sup>+/-</sup> and two controls (NUIGi022-A, NUIGi022-B; NUIGi023-A, NUIGi023-B; NUIGi025-A, NUIGi025-B; NUIGi024-A, NUIGi024-B; NUIGi026-A, NUIGi026-B)Yicheng Ding, Berta Marcó de la Cruz, Yawen Xia, et al.
Tissue Engineering. Part A|April 2, 2009
Neurotrophic factor-expressing mesenchymal stem cells survive transplantation into the contused spinal cord without differentiating into neural cellsGemma E Rooney, Siobhan S McMahon, Thomas Ritter, et al.
Stem Cell Research|February 26, 2020
Derivation of two iPSC lines from a sporadic ASD patient (NUIGi033-A) and a paternal control (NUIGi034-A)Berta Marcó de la Cruz, Yicheng Ding, Veronica McInerney, et al.
Critical Care Nursing Quarterly|December 14, 2011
Sternal wound care to prevent infections in adult cardiac surgery patientsLynda Stoodley, Linda Lillington, Lianna Ansryan, et al.
Cytotherapy|April 11, 2020
Autologous bone marrow mesenchymal stromal cell therapy for "no-option" critical limb ischemia is limited by karyotype abnormalitiesSara Azhari Mohamed, Linda Howard, Veronica McInerney, et al.
Stem Cell Research|February 12, 2021
Derivation of iPSC lines from two patients with autism spectrum disorder carrying NRXN1α deletion (NUIGi041-A, NUIG041-B; NUIGi045-A) and one sibling control (NUIGi042-A, NUIGi042-B)Yicheng Ding, Aisling O'Brien, Berta Marcó de la Cruz, et al.
Stem Cell Research|February 25, 2021
Derivation of four iPSC lines from a male ASD patient carrying a deletion in the middle coding region of NRXN1α gene (NUIGi039-A and NUIGi039-B) and a male sibling control (NUIGi040-A and NUIGi040-B)Yicheng Ding, Aisling O'Brien, Berta Marcó de la Cruz, et al.
Digestive Diseases and Sciences|October 8, 2016
Interventional EUS Using a Flexible 19-Gauge Needle: An International Multicenter Experience in 162 PatientsVivek Kumbhari, Irene Peñas, Alan H Tieu, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Stem Cell Research|December 29, 2020
Derivation of iPSC lines from three young healthy donors of Caucasian origin (NUIGi035-A; NUIGi036-A; NUIGi037-A)Yicheng Ding, Berta Marcó de la Cruz, Veronica McInerney, et al.
Cytotherapy|August 23, 2022
Marrow changes and reduced proliferative capacity of mesenchymal stromal cells from patients with "no-option" critical limb ischemia; observations on feasibility of the autologous approach from a clinical trialSara Azhari Mohamed, Aoife Duffy, Veronica McInerney, et al.
Stem Cell Research|November 24, 2019
Derivation of familial iPSC lines from three ASD patients carrying NRXN1α<sup>+/-</sup> and two controls (NUIGi022-A, NUIGi022-B; NUIGi023-A, NUIGi023-B; NUIGi025-A, NUIGi025-B; NUIGi024-A, NUIGi024-B; NUIGi026-A, NUIGi026-B)Yicheng Ding, Berta Marcó de la Cruz, Yawen Xia, et al.
Tissue Engineering. Part A|April 2, 2009
Neurotrophic factor-expressing mesenchymal stem cells survive transplantation into the contused spinal cord without differentiating into neural cellsGemma E Rooney, Siobhan S McMahon, Thomas Ritter, et al.
Stem Cell Research|February 26, 2020
Derivation of two iPSC lines from a sporadic ASD patient (NUIGi033-A) and a paternal control (NUIGi034-A)Berta Marcó de la Cruz, Yicheng Ding, Veronica McInerney, et al.
Critical Care Nursing Quarterly|December 14, 2011
Sternal wound care to prevent infections in adult cardiac surgery patientsLynda Stoodley, Linda Lillington, Lianna Ansryan, et al.
Cytotherapy|April 11, 2020
Autologous bone marrow mesenchymal stromal cell therapy for "no-option" critical limb ischemia is limited by karyotype abnormalitiesSara Azhari Mohamed, Linda Howard, Veronica McInerney, et al.
Stem Cell Research|February 12, 2021
Derivation of iPSC lines from two patients with autism spectrum disorder carrying NRXN1α deletion (NUIGi041-A, NUIG041-B; NUIGi045-A) and one sibling control (NUIGi042-A, NUIGi042-B)Yicheng Ding, Aisling O'Brien, Berta Marcó de la Cruz, et al.
Stem Cell Research|February 25, 2021
Derivation of four iPSC lines from a male ASD patient carrying a deletion in the middle coding region of NRXN1α gene (NUIGi039-A and NUIGi039-B) and a male sibling control (NUIGi040-A and NUIGi040-B)Yicheng Ding, Aisling O'Brien, Berta Marcó de la Cruz, et al.
Digestive Diseases and Sciences|October 8, 2016
Interventional EUS Using a Flexible 19-Gauge Needle: An International Multicenter Experience in 162 PatientsVivek Kumbhari, Irene Peñas, Alan H Tieu, et al.
Pageof 5